DK0702951T3 - Anvendelse af en NO-syntetaseinhibitor som lægemiddel til at reducere alkoholindtagelse eller forebygge overdreven alkoholindtagelse - Google Patents
Anvendelse af en NO-syntetaseinhibitor som lægemiddel til at reducere alkoholindtagelse eller forebygge overdreven alkoholindtagelseInfo
- Publication number
- DK0702951T3 DK0702951T3 DK95401781T DK95401781T DK0702951T3 DK 0702951 T3 DK0702951 T3 DK 0702951T3 DK 95401781 T DK95401781 T DK 95401781T DK 95401781 T DK95401781 T DK 95401781T DK 0702951 T3 DK0702951 T3 DK 0702951T3
- Authority
- DK
- Denmark
- Prior art keywords
- alcohol intake
- prevent excessive
- drug
- reduce
- synthetase inhibitor
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 5
- 102000003960 Ligases Human genes 0.000 title abstract 3
- 108090000364 Ligases Proteins 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- MRAUNPAHJZDYCK-BYPYZUCNSA-N L-nitroarginine Chemical compound OC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O MRAUNPAHJZDYCK-BYPYZUCNSA-N 0.000 abstract 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9409445A FR2722986B1 (fr) | 1994-07-29 | 1994-07-29 | Utilisation d'un inhibiteur de la no-synthetase comme medicament destine a reduire la consommation d'alcool ou prevenir l'exces de consommation d'alcool |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0702951T3 true DK0702951T3 (da) | 2002-01-14 |
Family
ID=9465903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95401781T DK0702951T3 (da) | 1994-07-29 | 1995-07-27 | Anvendelse af en NO-syntetaseinhibitor som lægemiddel til at reducere alkoholindtagelse eller forebygge overdreven alkoholindtagelse |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5639792A (pt) |
| EP (1) | EP0702951B1 (pt) |
| JP (1) | JPH0840889A (pt) |
| AT (1) | ATE206049T1 (pt) |
| DE (1) | DE69522881T2 (pt) |
| DK (1) | DK0702951T3 (pt) |
| ES (1) | ES2163480T3 (pt) |
| FR (1) | FR2722986B1 (pt) |
| PT (1) | PT702951E (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101256279B1 (ko) * | 2010-11-09 | 2013-04-18 | 대구한의대학교산학협력단 | 사우치논을 함유하는 약물중독 및 금단 증상의 예방 및 치료를 위한 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225440A (en) * | 1991-09-13 | 1993-07-06 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase |
-
1994
- 1994-07-29 FR FR9409445A patent/FR2722986B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-27 EP EP95401781A patent/EP0702951B1/fr not_active Expired - Lifetime
- 1995-07-27 DE DE69522881T patent/DE69522881T2/de not_active Expired - Fee Related
- 1995-07-27 ES ES95401781T patent/ES2163480T3/es not_active Expired - Lifetime
- 1995-07-27 DK DK95401781T patent/DK0702951T3/da active
- 1995-07-27 US US08/507,815 patent/US5639792A/en not_active Expired - Fee Related
- 1995-07-27 PT PT95401781T patent/PT702951E/pt unknown
- 1995-07-27 AT AT95401781T patent/ATE206049T1/de not_active IP Right Cessation
- 1995-07-31 JP JP7195146A patent/JPH0840889A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| PT702951E (pt) | 2002-02-28 |
| EP0702951B1 (fr) | 2001-09-26 |
| FR2722986A1 (fr) | 1996-02-02 |
| EP0702951A1 (fr) | 1996-03-27 |
| FR2722986B1 (fr) | 1996-10-25 |
| ES2163480T3 (es) | 2002-02-01 |
| ATE206049T1 (de) | 2001-10-15 |
| JPH0840889A (ja) | 1996-02-13 |
| US5639792A (en) | 1997-06-17 |
| DE69522881D1 (de) | 2001-10-31 |
| DE69522881T2 (de) | 2002-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25242A1 (es) | Inhibidores de benzotiazol de la proteína tirosina cinasa | |
| BRPI0413363A (pt) | formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase | |
| NO20023713D0 (no) | 2-benzotiazolyl-urea-derivater samt anvendelse derav som proteinkinaseinhibitorer | |
| AR033325A1 (es) | Composicion que comprende una carnitina y glutationa , util para incrementar la absorcion de la glutationa y sinergizar sus efectos, un complemento dietario, medicamento, la utilizacion de una composicion de combinacion para preparar un complemento dietario o un medicamento | |
| ES2196620T3 (es) | Formulacion de liberacion prolongada que contiene venlafaxina. | |
| BR0314058A (pt) | Composições para cuidados pessoais a base de álcool ramificado | |
| BR0315662A (pt) | Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona | |
| MXPA03004209A (es) | Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans. | |
| FI960850A (fi) | Kinoksaliinien käyttö proteaasi-inhibiittoreihin yhdistettyinä lääkkeeksi AIDS:in ja/tai HIV-tartuntojen hoitamiseksi | |
| DK1217999T3 (da) | Anvendelse af baclofen til behandling af alkoholisme | |
| AR038560A1 (es) | Una composicion antitranspirante/ desodorante | |
| EA200801875A1 (ru) | Антагонист cd 80 | |
| BR0314804A (pt) | Forma de dosagem de liberação modificada | |
| DK0702951T3 (da) | Anvendelse af en NO-syntetaseinhibitor som lægemiddel til at reducere alkoholindtagelse eller forebygge overdreven alkoholindtagelse | |
| ATE320422T1 (de) | Metalloproteinase inhibitoren | |
| DK1015437T3 (da) | Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler | |
| BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
| WO2000064422A3 (en) | Novel treatment of neurotraumatic conditions with raf inhibitor | |
| BR0313230A (pt) | Uso de carboxamidas para o tratamento de tinido | |
| FR2807645B1 (fr) | Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques | |
| SE0001071D0 (sv) | Method of inhibiting the expression of inflammatory cytokines and chemokines | |
| FI972367A0 (fi) | En mastanordning foer anvaendning vid brand- och raeddningsverksamhet | |
| TR200103398T2 (tr) | íkameli fenilsikloheksankarboksamitler ve bunlarìn adenozin alìnìmìnìn inhibitrleri olarak kullanìmì | |
| NL1022442C2 (nl) | Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen. | |
| AR023464A1 (es) | Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados |